What is the recommended dosage of Progynova (estradiol) for a patient with primary infertility, mild adenomyosis, and an ovarian cyst, starting on day 4 of the menstrual cycle with an endometrial thickness of 9.4 mm, in preparation for a donor embryo transfer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Progynova Initiation with 9.4mm Endometrium on Day 4

Continue Progynova 6mg daily for at least 8-10 more days (until day 12-14 of your cycle) before initiating progesterone, regardless of your current endometrial thickness of 9.4mm. 1

Standard HRT-FET Protocol for Donor Embryo Transfer

Your endometrial thickness of 9.4mm on day 4 is already adequate (target is ≥7-8mm), but timing of estrogen exposure duration is more critical than achieving a specific thickness. 1 The protocol requires:

  • Continue Progynova 6mg daily for a total of 12-14 days minimum before starting progesterone 1
  • This means you should continue estrogen until approximately day 12-14 of your cycle, not start progesterone on a fixed early day like day 9 1

Critical Monitoring Before Progesterone Initiation

Perform transvaginal ultrasound on day 12-14 to confirm: 1

  • Endometrial thickness remains ≥7-8mm (yours is already 9.4mm, which is excellent) 1, 2
  • Trilaminar endometrial pattern is present 1
  • The 11mm ovarian cyst remains stable (likely O-RADS 2, benign, and does not contraindicate transfer) 3, 4

Research shows that endometrial thickness up to 12mm is associated with progressively improved live birth rates (adjusted relative risk 1.07 for 12-14.9mm thickness in frozen cycles with PGT), so your current 9.4mm is favorable. 2

Why 12-14 Days of Estrogen Matters

Starting progesterone too early (before day 12-14) is a common pitfall that risks poor outcomes because: 1

  • Most patients require 12-14 days of estrogen priming before adequate endometrial transformation occurs 1
  • Embryo transfer timing must be precisely calculated from the first progesterone dose (blastocyst transfer at 117-120 hours after progesterone initiation) 1
  • Inadequate estrogen duration compromises endometrial receptivity despite adequate thickness 1, 5

Progesterone Initiation Protocol

Once you reach day 12-14 and confirm adequate endometrial preparation: 1

  • Start progesterone 800mg vaginal daily 1
  • Schedule blastocyst transfer for 117-120 hours (approximately 5 days) after first progesterone dose 1

Mandatory Single Embryo Transfer

For your donor embryo transfer, only elective single embryo transfer (eSET) should be performed—this is non-negotiable. 6, 7, 3 The ESHRE guidelines mandate eSET for all donated embryo transfers with no exceptions, regardless of: 7, 3

  • Your endometrial thickness (even though 9.4mm is excellent) 6, 7
  • Presence of mild adenomyosis 7, 3
  • The 11mm ovarian cyst 3
  • Any previous failed cycles or duration of infertility 6, 7

The rationale is clear: double embryo transfer increases multiple pregnancy risk 30-fold (OR 30.54,95% CI 7.46-124.95), with substantially elevated risks of pre-eclampsia, gestational diabetes, emergency cesarean section, preterm birth, and neonatal complications—risks that would be particularly problematic in a uterus with adenomyosis. 7, 3

Adenomyosis Considerations

Your mild adenomyosis does not change the treatment protocol or contraindicate transfer, but it reinforces the importance of single embryo transfer to avoid multiple pregnancy complications in an already compromised uterine environment. 3, 8 Adenomyosis prevalence is 24.4% in infertile women and 34.7% in those with previous ART failure, so your case is not unusual. 8

References

Guideline

Progesterone Initiation Timing in HRT-FET Cycles

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Donor Embryo Transfer Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Structural Gynecological Disease: Fibroids, Endometriosis, Ovarian Cysts.

The Medical clinics of North America, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Elective Single Embryo Transfer Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Is an endometrium thickness of 9.4 mm on day 4 of the cycle adequate for a donor embryo transfer in a patient with primary infertility, a mildly adenomyotic uterus, and an 11 mm ovarian cyst?
What is the management plan for a 21-year-old female with a suspected small calcified fibroid (echogenic focus) in the uterine myometrium, who has a history of ruptured ovarian cyst and presented with pain during ultrasound?
What's the next step for a 48-year-old woman with heavy menstrual bleeding, uterine polyp, ovarian cyst, dehydration, muscle cramps, and risk of iron deficiency anemia, currently taking naproxen (nonsteroidal anti-inflammatory drug) and iron supplements?
What is the recommended duration of antibiotic therapy after surgical removal of a fibroid and a twisted ovary?
What is the recommended next step in managing a 69-year-old patient with a history of menorrhagia, adenomyosis, endometriosis, and a cystic mass in the posterior cul-de-sac (POD) region, with multiple small uterine fibroids and bilateral enlarged ovaries?
What is the prevalence of pulmonary tuberculosis (PTB) in a patient with Chronic Obstructive Pulmonary Disease (COPD) on triple therapy, including inhaled corticosteroids (ICS), long-acting beta-agonists (LABAs), and long-acting muscarinic antagonists (LAMAs)?
What is the average lifespan of an individual with Functional Neurological Disorder (FND)?
What is the appropriate management for a 48-year-old male with knee joint pain, hyperuricemia, impaired glucose regulation (HbA1c 6.5), hyperkalemia, elevated CPK, and inflammation?
Why does Functional Neurological Disorder (FND) not affect an individual's lifespan?
What is the preferred testing approach, germline testing or somatic testing, for a patient with a suspected BRCA (Breast Cancer Gene) mutation and no personal history of breast or ovarian cancer?
How is pregnancy-induced thrombocytopenia managed in pregnant women?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.